SATOSEA Trademark

Trademark Overview

On Friday, June 5, 2020, a trademark application was filed for SATOSEA with the United States Patent and Trademark Office. The USPTO has given the SATOSEA trademark a serial number of 88949840. The federal status of this trademark filing is REGISTERED as of Tuesday, January 18, 2022. This trademark is owned by Ipsen Pharma S.A.S.. The SATOSEA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting clinical trials for others; Conducting clinical trials for others in the field of pharmaceutical products; Testing of pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
satosea

General Information

Serial Number88949840
Word MarkSATOSEA
Filing DateFriday, June 5, 2020
Status700 - REGISTERED
Status DateTuesday, January 18, 2022
Registration Number6617650
Registration DateTuesday, January 18, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 2, 2021

Trademark Statements

Translation of Words in MarkThe wording "SATOSEA" has no meaning in a foreign language.
Goods and ServicesConducting clinical trials for others; Conducting clinical trials for others in the field of pharmaceutical products; Testing of pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 26, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIpsen Pharma S.A.S.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBoulonge-Billancourt 92100
FR
Party NameIpsen Pharma S.A.S.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBoulonge-Billancourt 92100
FR
Party NameIpsen Pharma S.A.S.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBoulogne Billancourt 92100
FR

Trademark Events

Event DateEvent Description
Wednesday, November 2, 2022WITHDRAWAL OF ATTORNEY GRANTED
Wednesday, November 2, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Thursday, January 20, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 20, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, January 20, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 20, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 18, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, January 6, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 6, 2022TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Thursday, January 6, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, January 6, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 6, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 30, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 30, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 30, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 30, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 30, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 2, 2021PUBLISHED FOR OPPOSITION
Wednesday, October 13, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 29, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 29, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 20, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 20, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 20, 2021ASSIGNED TO LIE
Tuesday, September 14, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, May 3, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, May 3, 2021INQUIRY TO SUSPENSION E-MAILED
Monday, May 3, 2021SUSPENSION INQUIRY WRITTEN
Tuesday, October 13, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, October 13, 2020LETTER OF SUSPENSION E-MAILED
Tuesday, October 13, 2020SUSPENSION LETTER WRITTEN
Wednesday, October 7, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 7, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 6, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 10, 2020NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, September 10, 2020PRIORITY ACTION E-MAILED
Thursday, September 10, 2020PRIORITY ACTION WRITTEN
Wednesday, September 9, 2020ASSIGNED TO EXAMINER
Friday, June 26, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 9, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

satosea trials clinical pharmaceuticals conducting field others scientific research medical information